Fujifilm Diosynth Commissions New Cell Banking Facility

Fujifilm Diosynth Biotechnologies has commissioned its new mammalian cGMP Cell Banking Facility (CBF) at its Billingham, UK site. The new CBF is available to customers either as part of a larger development and manufacturing program, or as a stand-alone service. The CBF will support manufacturing programs for both the Billingham UK, and Research Triangle Park, NC facilities.
 
The next stage of the company’s expansion is a new cGMP manufacturing facility in Billingham, which is scheduled to open in early 4Q13. The manufacturing facility will primarily utilize single-use technologies and will initially offer 200L and 1000L single-use bioreactors, with 2000L bioreactors planned for 2014.
 
Steve Bagshaw, managing director, Fujifilm Diosynth Biotechnologies UK, said “I am delighted that we have commissioned the Cell Bank Facility within a year of its commencement, and have already started work on our first customer program. This is the next step in our strategy to grow our services in the CDMO field, becoming a world-class player across both microbial and mammalian cell culture platforms, offering a full life cycle support for our customers.”